Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

Cannabidiol and Other Cannabinoids Reduce Microglial Activation In Vitro and In Vivo: Relevance to Alzheimer's Disease

Ana María Martín-Moreno, David Reigada, Belén G. Ramírez, R. Mechoulam, Nadia Innamorato, Antonio Cuadrado and María L. de Ceballos
Molecular Pharmacology June 2011, 79 (6) 964-973; DOI: https://doi.org/10.1124/mol.111.071290
Ana María Martín-Moreno
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Reigada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Belén G. Ramírez
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
R. Mechoulam
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nadia Innamorato
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Antonio Cuadrado
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
María L. de Ceballos
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 79 no. 6 964-973
DOI 
https://doi.org/10.1124/mol.111.071290
PubMed 
21350020

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0026-895X
Online ISSN 
1521-0111
History 
  • Received January 18, 2011
  • Accepted February 11, 2011
  • Published online May 17, 2011.

Article Versions

  • Earlier version (February 24, 2011 - 10:44).
  • You are viewing the most recent version of this article.
Copyright & Usage 
Copyright © 2011 The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Ana María Martín-Moreno,
  2. David Reigada1,
  3. Belén G. Ramírez2,
  4. R. Mechoulam,
  5. Nadia Innamorato,
  6. Antonio Cuadrado and
  7. María L. de Ceballos
  1. Neurodegeneration Group, Department of Cellular, Molecular and Developmental Neurobiology, Instituto Cajal, Consejo Superior de Investigaciones Cientificas, Madrid, Spain (A.M.M.-M., D.R., B.G.R., M.L.C.); Centro de Investigación en Red en Enfermedades Neurodegenerativas (A.M.M.-M., D.R., B.G.R., M.L.C., N.I., A.C.) and Institute for Drug Research, Medical Faculty, Hebrew University (R.M.), Jerusalem, Israel; and Departamento de Bioquímica, Instituto de Investigaciones Biomédicas “Alberto Sols” UAM-Consejo Superior de Investigaciones Cientificas, Facultad de Medicina, Universidad Autónoma de Madrid, Madrid, Spain (N.I., A.C.)
  1. Address correspondence to:
    Dr. M. L. de Ceballos, Neurodegeneration Group, Department of Cellular, Molecular and Developmental Neurobiology, Instituto Cajal, CSIC, Doctor Arce, 37, 28002 Madrid, Spain. E-mail: mceballos{at}cajal.csic.es
  1. A.M.M.-M. and D.R. contributed equally to this work.

  • ↵1 Current affiliation: Molecular Neuroprotection Group, Experimental Neurology Unit, Paraplejic National Hospital, Toledo, Spain.

  • ↵2 Current affiliation: Unidad de Apoyo a la Investigación, Fundación MD Anderson Internacional España, Madrid, Spain.

View Full Text

Statistics from Altmetric.com

Article usage

Article usage: February 2011 to August 2022

AbstractFullPdf
Feb 20111110204
Mar 20111910662
Apr 20111200318
May 201133427210
Jun 201131245111
Jul 201111722104
Aug 2011964172
Sep 2011892890
Oct 2011754676
Nov 2011673191
Dec 2011532863
Jan 2012812477
Feb 2012551689
Mar 2012901975
Apr 2012621792
May 2012613278
Jun 2012512952
Jul 2012374164
Aug 2012313050
Sep 2012312561
Oct 2012444468
Nov 2012765582
Dec 2012392267
Jan 2013574262
Feb 2013563161
Mar 2013623271
Apr 2013454369
May 2013433368
Jun 2013312717
Jul 2013374354
Aug 2013212556
Sep 2013472941
Oct 2013322940
Nov 2013333055
Dec 2013483756
Jan 2014323684
Feb 2014492558
Mar 2014483658
Apr 2014353343
May 2014362666
Jun 20144727104
Jul 2014631947
Aug 2014244943
Sep 2014373237
Oct 2014654851
Nov 2014465764
Dec 2014373946
Jan 2015721844
Feb 2015394332
Mar 2015373140
Apr 2015533847
May 2015562644
Jun 2015262634
Jul 2015422674
Aug 2015603027
Sep 2015502028
Oct 2015432344
Nov 2015462931
Dec 2015332236
Jan 2016452038
Feb 2016152725
Mar 2016301726
Apr 2016216340
May 2016301837
Jun 201617929
Jul 2016442029
Aug 2016161736
Sep 2016282837
Oct 2016242526
Nov 2016275729
Dec 201630416
Jan 2017494629
Feb 2017504419
Mar 2017455826
Apr 2017414016
May 2017584329
Jun 2017545241
Jul 2017363417
Aug 2017345312
Sep 2017873822
Oct 2017596117
Nov 20176611764
Dec 20173320821
Jan 20186820039
Feb 2018677230
Mar 20185816049
Apr 20184614145
May 20186413857
Jun 201817213437
Jul 20184110536
Aug 20187918442
Sep 20185519751
Oct 20186521460
Nov 20185420653
Dec 20182034522
Jan 20192321019
Feb 20192331322
Mar 2019253725
Apr 2019227617
May 2019201420
Jun 2019205218
Jul 2019214915
Aug 2019198763
Sep 20192251131
Oct 20192458126
Nov 20192353162
Dec 20192054205
Jan 202023917178
Feb 20202691712
Mar 20203311513
Apr 202035017
May 20203961212
Jun 202023685
Jul 202021385
Aug 20202161019
Sep 20202133642
Oct 20202894345
Nov 20202893425
Dec 20202463027
Jan 20212061520
Feb 20212341816
Mar 20212992517
Apr 20213391118
May 20213041716
Jun 20212251616
Jul 2021228818
Aug 2021270128
Sep 2021290713
Oct 20213841214
Nov 20213001215
Dec 20213311914
Jan 20222451131
Feb 2022327936
Mar 2022457651
Apr 20222891216
May 2022300158
Jun 202230967
Jul 202226777
Aug 202212531

PreviousNext
Back to top

In this issue

Molecular Pharmacology: 79 (6)
Molecular Pharmacology
Vol. 79, Issue 6
1 Jun 2011
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Cannabidiol and Other Cannabinoids Reduce Microglial Activation In Vitro and In Vivo: Relevance to Alzheimer's Disease
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Cannabidiol and Other Cannabinoids Reduce Microglial Activation In Vitro and In Vivo: Relevance to Alzheimer's Disease

Ana María Martín-Moreno, David Reigada, Belén G. Ramírez, R. Mechoulam, Nadia Innamorato, Antonio Cuadrado and María L. de Ceballos
Molecular Pharmacology June 1, 2011, 79 (6) 964-973; DOI: https://doi.org/10.1124/mol.111.071290

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Cannabidiol and Other Cannabinoids Reduce Microglial Activation In Vitro and In Vivo: Relevance to Alzheimer's Disease

Ana María Martín-Moreno, David Reigada, Belén G. Ramírez, R. Mechoulam, Nadia Innamorato, Antonio Cuadrado and María L. de Ceballos
Molecular Pharmacology June 1, 2011, 79 (6) 964-973; DOI: https://doi.org/10.1124/mol.111.071290
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Authorship Contributions
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Anti-aromatase activity of exemestane phase II metabolites
  • α-Conotoxin Binding Site on the GABAB Receptor
  • Upacicalcet binds to the amino acid binding site of CaSR
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics